dibutyl phthalate has been researched along with gsk239512 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apps, J; Bailey, N; Bamford, MJ; Beresford, IJ; Brackenborough, K; Briggs, MA; Brough, S; Calver, AR; Crook, B; Davis, RK; Davis, RP; Davis, S; Dean, DK; Harris, L; Heslop, T; Holland, V; Jeffrey, P; Medhurst, AD; Panchal, TA; Parr, CA; Quashie, N; Schogger, J; Sehmi, SS; Steadman, JG; Stean, TO; Takle, AK; Trail, B; Wald, J; Wilson, DM; Witherington, J; Worby, A | 1 |
1 other study(ies) available for dibutyl phthalate and gsk239512
Article | Year |
---|---|
Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists.
Topics: Animals; Benzazepines; Dogs; Half-Life; Haplorhini; Histamine H3 Antagonists; Humans; Male; Microsomes, Liver; Niacinamide; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Histamine H3; Structure-Activity Relationship | 2013 |